Search


Biotech CEO Sisterhood: X4 Pharmaceuticals' CEO Paula Ragan on her career and running a commercial stage company in the rare disease space
Interviewed by Sisterhood editorial board member Erika Smith, Paula Ragan shares her career path and things she has learned along the...
Apr 8


X4 Pharma's CEO on the recent launch of XOLREMDI for WHIM Syndrome and CXCR4 inhibition more broadly for additional indications
Paula Ragan describes the launch of this medicine that was approved at the end of April and previews an upcoming data announcement X4...
Jun 7, 2024